Table 1 Clinicopathological characteristics of cluster 1 and cluster 2 in LUAD patients.
Characteristic | Total | Cluster 1(n = 250) | Cluster 2(n = 225) | P Value | ||
|---|---|---|---|---|---|---|
No. of patients | % | No. of patients | % | |||
Gender | ||||||
Female | 253 | 124 | 49.01 | 129 | 50.99 | 0.092 |
Male | 222 | 126 | 56.76 | 96 | 43.24 | |
Age | ||||||
≤ 65 | 227 | 139 | 61.23 | 88 | 38.77 | < 0.001 |
> 65 | 248 | 111 | 44.76 | 137 | 55.24 | |
TNM stage | ||||||
Stage I–II | 374 | 185 | 49.47 | 189 | 50.53 | 0.002 |
Stage III–IV | 101 | 65 | 64.36 | 36 | 35.64 | |
T stage | ||||||
T1–T2 | 413 | 213 | 51.57 | 200 | 48.42 | 0.004 |
T3–T4 | 62 | 37 | 59.68 | 25 | 40.32 | |
M stage | ||||||
M0 | 317 | 169 | 53.31 | 148 | 46.69 | 0.418 |
M1 | 22 | 14 | 63.63 | 8 | 36.36 | |
MX | 136 | 67 | 49.26 | 69 | 50.74 | |
N stage | ||||||
N0–N1 | 404 | 205 | 50.74 | 199 | 49.26 | 0.001 |
N2–N3 | 71 | 45 | 63.38 | 26 | 36.62 | |
